Cell kinetics as a prognostic marker in node-negative breast cancer

Area of Science:

• Oncology
• Cell Biology
• Biostatistics

Background:

• Assessing biologic aggressiveness is crucial for breast cancer prognosis.
• Cell kinetics offers potential insights into tumor behavior.

Purpose of the Study:

• To evaluate the prognostic relevance of primary tumor cell kinetics in operable breast cancer.
• To determine if cell proliferation rate predicts metastatic potential and survival outcomes.

Main Methods:

• Analysis of 258 operable breast cancer patients without nodal or distant metastases.
• In vitro evaluation of cell proliferative rate using 3H-thymidine labeling index on fresh tumor tissue.
• Long-term follow-up for relapse-free survival and overall survival.

Main Results:

• A higher cell proliferative rate was significantly associated with increased metastatic potential and poorer 6-year relapse-free survival (80.5% vs. 59.6%, P=0.00004).
• This prognostic value held true across premenopausal, paramenopausal, and postmenopausal patient groups.
• Cell kinetics also proved to be a significant discriminant of 6-year survival for the overall cohort and pre/paramenopausal subgroups.

Conclusions:

• Tumor cell kinetics, specifically the proliferation rate, is a relevant and significant prognostic marker in breast cancer.
• This kinetic variable aids in identifying patients at higher risk of relapse and mortality.
• The findings support the integration of cell kinetic analysis into breast cancer prognostic assessments.